Pathobiological considerations relating to the treatment of intraductal carcinoma (ductal carcinoma in situ) of the breast

被引：22

作者：

Fisher, ER ^{[1
]}

机构：

[1] NATL SURG ADJUVANT BREAST & BOWEL PROJECT,PITTSBURGH,PA

来源：

CA-A CANCER JOURNAL FOR CLINICIANS | 1997年 / 47卷 / 01期

关键词：

D O I：

10.3322/canjclin.47.1.52

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Management of ductal carcinoma in situ has become one of the most controversial topics in breast disease. While mastectomy has been the traditional treatment, many now feel it is excessive in most cases. As a result, a great effort has been made to identify pathobiological characteristics of DCIS that can be used to stratify appropriate treatment decisions. This article reviews efforts to relate pathobiological characteristics to disease management and provides treatment recommendations based on the latest evidence.

引用

页码：52 / 64

页数：13

共 65 条

[21]

2-L

[22]

FISHER ER, 1995, CANCER-AM CANCER SOC, V75, P1310, DOI 10.1002/1097-0142(19950315)75:6<1310::AID-CNCR2820750613>3.0.CO

[23]

2-G

[24]

FISHER ER, IN PRESS DUCTAL CARC

[25]

GILLIS DA, 1960, SURG GYNECOL OBSTET, V110, P555

[26]

HOLLAND R, 1994, SEMIN DIAGN PATHOL, V11, P167

[27]

LAGIOS MD, 1982, CANCER-AM CANCER SOC, V50, P1309, DOI 10.1002/1097-0142(19821001)50:7<1309::AID-CNCR2820500716>3.0.CO

[28]

2-#

[29]

LAGIOS MD, 1989, CANCER, V63, P618, DOI 10.1002/1097-0142(19890215)63:4<618::AID-CNCR2820630403>3.0.CO

[30]

2-J

← 1 2 3 4 5 6 7 →